ストックスクリーナーアプリを入手
1.63
5.84%
0.09
前日終値:
$1.54
開ける：
$1.5
24時間の取引高:
2.64M
Relative Volume:
0.16
時価総額：
$158.99M
収益：
$1.20M
当期純損益:
$-52.41M
株価収益率:
-1.7912
EPS:
-0.91
ネットキャッシュフロー:
$-31.25M
1週間 パフォーマンス:
-13.30%
1か月 パフォーマンス:
-42.81%
6か月 パフォーマンス:
+130.16%
1年 パフォーマンス:
-20.10%
1日の値動き範囲:
$1.46
$1.695
1週間の範囲:
$1.46
$1.9885
52週間の値動き範囲:
$0.387
$3.87
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
名前
Rani Therapeutics Holdings Inc
セクター
電話
(408) 457-3700
住所
2051 RINGWOOD AVENUE, SAN JOSE
RANI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
1.63 | 150.21M | 1.20M | -52.41M | -31.25M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-02 | 開始されました | Oppenheimer | Outperform |
| 2024-06-14 | 開始されました | Maxim Group | Buy |
| 2024-06-13 | 開始されました | Rodman & Renshaw | Buy |
| 2023-04-17 | 再開されました | BTIG Research | Buy |
| 2022-10-11 | 開始されました | UBS | Buy |
| 2022-07-27 | 開始されました | H.C. Wainwright | Buy |
| 2022-06-13 | 開始されました | Wedbush | Outperform |
すべてを表示
Rani Therapeutics Holdings Inc (RANI) 最新ニュース
Will Rani Therapeutics Holdings Inc. stock gain from government policiesMarket Movement Recap & Consistent Profit Trading Strategies - newser.com
Technical analysis overview for Rani Therapeutics Holdings Inc. stockJuly 2025 Selloffs & Reliable Trade Execution Plans - newser.com
Is Rani Therapeutics Holdings Inc. stock trading at a premium valuationEarnings Overview Report & Low Drawdown Trading Techniques - newser.com
RANI Stock Today (Nov 19, 2025): Rani Therapeutics slips to $1.75 as traders weigh October’s Chugai deal and year‑end catalysts - ts2.tech
How Rani Therapeutics Holdings Inc. stock compares to market leadersQuarterly Portfolio Review & Consistent Growth Equity Picks - newser.com
Institutional scanner results for Rani Therapeutics Holdings Inc.Earnings Summary Report & Daily Momentum Trading Reports - newser.com
How high can Rani Therapeutics Holdings Inc. stock goLong Setup & Consistent Income Trade Ideas - newser.com
Short interest data insights for Rani Therapeutics Holdings Inc.July 2025 Market Mood & Weekly Momentum Picks - newser.com
How Rani Therapeutics Holdings Inc. stock benefits from global expansionVolume Spike & Weekly Watchlist for Hot Stocks - newser.com
Vasudev Jaiprakash Bailey Net Worth (2025) - GuruFocus
Will Rani Therapeutics Holdings Inc. bounce back from current supportStock Surge & AI Forecasted Entry/Exit Points - newser.com
How to integrate Rani Therapeutics Holdings Inc. into portfolio analysis toolsJuly 2025 Drop Watch & Low Drawdown Investment Strategies - newser.com
Rani Therapeutics Holdings (RANI) Price Target Decreased by 11.90% to 9.44 - MSN
Is Rani Therapeutics Holdings Inc. stock a buy for dividend growthJuly 2025 Retail & Advanced Technical Signal Analysis - newser.com
Is Rani Therapeutics Holdings Inc. stock supported by innovation pipeline2025 Key Lessons & Breakout Confirmation Alerts - newser.com
Can Rani Therapeutics Holdings Inc. stock maintain growth trajectoryGap Up & Safe Entry Trade Reports - Fundação Cultural do Pará
Will Rani Therapeutics Holdings Inc. stock attract more institutional investorsJuly 2025 Reactions & Momentum Based Trading Ideas - newser.com
MSN Money - MSN
Rani Therapeutics Reports Financial Challenges Amid Innovation - MSN
RANI: Third Quarter Results - Zacks Small Cap Research
Rani Therapeutics Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Rani Therapeutics Secures Funding And A Billion-Dollar Pharma Deal - Finimize
Rani Therapeutics Holdings Inc (RANI) 財務データ
収益
当期純利益
現金流量
EPS
Rani Therapeutics Holdings Inc (RANI) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| South Cone Investments Limited | 10% Owner |
Oct 21 '25 |
Sale |
2.77 |
4,000,000 |
11,074,000 |
2,379,194 |
| South Cone Investments Limited | 10% Owner |
Oct 20 '25 |
Sale |
2.41 |
1,923,000 |
4,637,314 |
6,379,194 |
| McKinley Kate | Chief Business Officer |
Dec 13 '24 |
Buy |
1.67 |
17,960 |
29,993 |
17,960 |
| Imran Talat | Chief Executive Officer |
Dec 09 '24 |
Buy |
1.94 |
10,296 |
19,974 |
494,751 |
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):